- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Wockhardt Limited — Updates, 30-05-2026: Press Release
30-05-2026 | 06:15 pm
30-05-2026 | 06:15 pm
Wockhardt received U.S. FDA approval for ZAYNICH™, a novel intravenous antibiotic for complicated urinary tract infections. This marks a historic milestone as the first New Chemical Entity fully developed by an Indian pharma company to receive FDA approval.
No comments yet. Be the first to comment!